<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04886011</url>
  </required_header>
  <id_info>
    <org_study_id>KFSAPH2021</org_study_id>
    <nct_id>NCT04886011</nct_id>
  </id_info>
  <brief_title>Camel Whey Protein Gel for the Treatment of Aphthous Ulcer</brief_title>
  <official_title>Evaluation of Novel Topical Camel Whey Protein Gel for the Treatment of Recurrent Aphthous Stomatitis: Randomised Clinical Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kafrelsheikh University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kafrelsheikh University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Higher prevalence of recurrent aphthous ulcer in young adults and the severity decreased with&#xD;
      increasing age. The etiology of aphthous ulcer remains unclear. Other possible factors&#xD;
      include trauma, drug use, deficiency in vitamin B12, folic acid, iron, stress, hormonal&#xD;
      changes and metabolic diseases. Many topical agents such as local and systemic an- tibiotics,&#xD;
      local antiseptics, topical NSAIDs, and topical corticosteroids are generally prescribed for&#xD;
      symptomatic relief. Several approved drug for- mulations such as pills, mouthwash, sprays and&#xD;
      paste such as vitamin B12, chlorhexidine mouthwash, steroid lozenges and local anesthetics&#xD;
      are primarily suggested for the treatment of aphthous ulcer.&#xD;
&#xD;
      Camel whey protein gel was fabricated to get benefits of its antiinflammatory,&#xD;
      immunomodulator, Antibacterial and antioxidant effects.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      40 cases of recurrent aphthous ulcer patients as the research object,were randomly divide&#xD;
      into the study group and the control group, each with 20 cases of both sexes with age ranging&#xD;
      from 18 years to 50 years.&#xD;
&#xD;
      Inclusion criteria consisted of the following: (a) clinical examination and confirmed history&#xD;
      of recurrent oral ulcer, (b) recurrence of the oral ulceration, and (c) patients in good&#xD;
      condition with no serious systemic disease. Eligible persons were excluded if they were&#xD;
      administered antibiotics or glucocorticoids or accepted periodontal or dental treat- ments&#xD;
      that interfered with the results of our experimental drugs.&#xD;
&#xD;
      the control group will be subjected to placebo gel consisting of methyl cellulose gel whereas&#xD;
      the study group will use camel whey protein dissolved in methyl cellulose gel base. the gel&#xD;
      will be applied 1 day after ulcer appearance and will be stopped after ulcer disappearance&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 15, 2021</start_date>
  <completion_date type="Anticipated">August 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">August 15, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Methylcellulose gel</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>pain level</measure>
    <time_frame>1 week</time_frame>
    <description>visual analog scale to measure pain level from 0 to 10. 0 means no pain at all and 10 means the most sever pain</description>
  </primary_outcome>
  <primary_outcome>
    <measure>ulcer duration</measure>
    <time_frame>10 days</time_frame>
    <description>time extended from ulcer presence till disseverance</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>immunological analysis</measure>
    <time_frame>10 days</time_frame>
    <description>the values of serum TNF-Î±, Il1, IL6 were measured before and after gel application using flow cytometry</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Aphthous Stomatitis, Recurrent</condition>
  <condition>Antioxidative Stress</condition>
  <arm_group>
    <arm_group_label>placebo gel</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Methylcellulose gel was applied to the ulcer till complete healing</description>
  </arm_group>
  <arm_group>
    <arm_group_label>camel whey protein gel</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>camel whey protein dissolved in methycellulose gel was applied to the ulcer till complete healing</description>
  </arm_group>
  <intervention>
    <intervention_type>Combination Product</intervention_type>
    <intervention_name>placebo gel</intervention_name>
    <description>just methyl cellulose gel was applied to the ulcer</description>
    <arm_group_label>placebo gel</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Combination Product</intervention_type>
    <intervention_name>camel whey protein gel</intervention_name>
    <description>camel whey protein gel was prepared and dissolved in methyl cellulose gel base and applied to the ulcer</description>
    <arm_group_label>camel whey protein gel</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  clinical examination and confirmed history of recurrent oral ulcer,&#xD;
&#xD;
          -  recurrence of the oral ulceration&#xD;
&#xD;
          -  patients in good condition with no serious systemic disease.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  if they were administered antibiotics or glucocorticoids&#xD;
&#xD;
          -  accepted periodontal or dental treat-ments that interfered with the results of our&#xD;
             experimental drugs&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>walid elamrousy, pHDh</last_name>
    <phone>+201005724781</phone>
    <email>waled_hammed@den.kfs.edu.eg</email>
  </overall_contact>
  <location>
    <facility>
      <name>oral medicine and periodontology outpatient clinic, faculty of dentistry, kafrelsheikh University</name>
      <address>
        <city>Kafr Ash Shaykh</city>
        <state>Kafrelsheikh</state>
        <zip>214312</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>walid elamrousy, phd</last_name>
      <phone>+201005724781</phone>
      <email>Waled_Hammed@den.kfs.edu.eg</email>
    </contact>
    <contact_backup>
      <last_name>mostafa fayed, bachelor</last_name>
      <phone>+201063376252</phone>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Walid Elamrousy</name>
      <address>
        <city>Kafr Ash Shaykh</city>
        <zip>21614</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>walid elamrousy</last_name>
      <phone>01005724781</phone>
      <email>waled_hammed@den.kfs.edu.eg</email>
    </contact>
    <investigator>
      <last_name>dalia rasheed, phd</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>May 8, 2021</study_first_submitted>
  <study_first_submitted_qc>May 8, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 13, 2021</study_first_posted>
  <last_update_submitted>July 21, 2021</last_update_submitted>
  <last_update_submitted_qc>July 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 27, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kafrelsheikh University</investigator_affiliation>
    <investigator_full_name>Walid Elamrousy</investigator_full_name>
    <investigator_title>Principle investivagor and lecturer of oral medicine and periodontology, faculty of dentistry, kafrelsheikh university</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stomatitis</mesh_term>
    <mesh_term>Stomatitis, Aphthous</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

